Kevzara 150 mg/1.14 ml

Kevzara 150 mg/1.14 ml is a medicine authorised by Swissmedic under authorisation number 66424. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 20 April 2018 and the authorisation is valid without a time limit. ATC code L04AC14 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 66424
  • ATC L04AC14
  • Biotechnological medicines
Authorisation data
Authorisation number66424
NameKevzara 150 mg/1.14 ml
Full nameKevzara 150 mg/1.14 ml, solution pour injection en seringue préremplie
Authorisation holderSanofi-Aventis (Suisse) SA
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeL04AC14
First authorisation20 April 2018
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Kevzara 150 mg/1.14 ml, solution pour injection en seringue préremplieB20 April 2018
2Kevzara 200 mg/1.14 ml, solution pour injection en seringue préremplieB20 April 2018

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
12Fertigspritze(n)L04AC1407.15.0.B
32Fertigspritze(n)L04AC1407.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Kevzara 150 mg/1.14 ml authorised in Switzerland?

Yes. Kevzara 150 mg/1.14 ml is authorised by Swissmedic under authorisation number 66424, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Kevzara 150 mg/1.14 ml have?

Kevzara 150 mg/1.14 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Kevzara 150 mg/1.14 ml?

The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com